Search - tctmd.com

Displaying 1 - 20 of 57

Sort: Relevancy | Date

Presentation TCT 2016

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Deepak L. Bhatt

November 01, 2016

Presentation TCT 2016

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI

Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt

November 01, 2016

Presentation TCT 2016

Biodegradable Scaffolds In STEMI: Rationale, Registry outcomes (Literature search) and TROFI II 2-year Results

Presenter: Deepak L. Bhatt, Stefan K. James, Manel Sabate

October 31, 2016

Presentation TCT 2016

Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices?

Presenter: Deepak L. Bhatt, Stefan K. James, Tullio Palmerini

October 31, 2016

Presentation TCT 2016

Is There a Current Role for Intracoronary Lytics or GP IIb/IIIa Inhibitors During Primary PCI?

Presenter: Deepak L. Bhatt, Stefan K. James, C. Michael Gibson

October 31, 2016

Presentation TCT 2016

Debate: Does Radial Access Really Improve Survival for STEMI? Yes - Radial Intervention for STEMI Improves Survival and Should Be Standard Practice!

Presenter: Deepak L. Bhatt, Stefan K. James, Michael A. Kutcher

October 31, 2016

Presentation TCT 2016

New Insights Into Thrombus Aspiration for STEMI: Results From the TOTAL Angiographic Core Lab

Presenter: Deepak L. Bhatt, Stefan K. James, Christopher Overgaard

October 31, 2016

Presentation TCT 2016

Aspiration Thrombectomy in STEMI: Data Synthesis, and How to Identify Patients Who Might Benefit

Presenter: Deepak L. Bhatt, Stefan K. James, Eric A. Cohen

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

Presenter: Deepak L. Bhatt, Roxana Mehran, Michael S. Lauer

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Advantages and Caveats

Presenter: Deepak L. Bhatt, Roxana Mehran, Robert A. Harrington

October 31, 2016

Presentation TCT 2016

Debate: Making the Case for Very Limited Use of Cangrelor!

Presenter: Deepak L. Bhatt, Christian W. Hamm, Sorin J. Brener

October 30, 2016

Presentation TCT 2016

Debate: Making the Case for Cangrelor Use in All PCI Patients!

Presenter: Deepak L. Bhatt, Christian W. Hamm, Franz-Josef Neumann

October 30, 2016

Presentation TCT 2016

Transitioning Between Cangrelor and Oral P2Y12 Inhibitors: All the Permutations

Presenter: Deepak L. Bhatt, Christian W. Hamm, Paul A. Gurbel

October 30, 2016

Presentation TCT 2016

Cangrelor Deep Dive: What Have We Learned From the CHAMPION Trials?

Presenter: Deepak L. Bhatt, Christian W. Hamm

October 30, 2016

Presentation ESC 2016

“Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX

Presenter: Deepak L. Bhatt

August 31, 2016

Presentation TCT 2015

Cangrelor IV: Transitioning to Oral ADP Antagonists

Presenter: Deepak L. Bhatt, Robert A. Harrington, Harvey D. White

October 15, 2015

Presentation TCT 2015

Cangrelor III: Effects on Intraprocedural and Postprocedural Stent Thrombosis

Presenter: Deepak L. Bhatt, Robert A. Harrington, Harvey D. White, Philippe Généreux

October 15, 2015

Presentation TCT 2015

Cangrelor II: Perspectives on in Whom to Actually Use It

Presenter: Deepak L. Bhatt, Robert A. Harrington, Harvey D. White

October 15, 2015

Presentation TCT 2015

Cangrelor I: Data Essentials From the Champion Trials

Presenter: Deepak L. Bhatt, Robert A. Harrington, Harvey D. White

October 15, 2015

Presentation TCT 2015

The RE-DUAL PCI Trial (Dabigatran in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Deepak L. Bhatt

October 14, 2015

Advertisement

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI

Biodegradable Scaffolds In STEMI: Rationale, Registry outcomes (Literature search) and TROFI II 2-year Results

Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices?

Is There a Current Role for Intracoronary Lytics or GP IIb/IIIa Inhibitors During Primary PCI?

Debate: Does Radial Access Really Improve Survival for STEMI? Yes - Radial Intervention for STEMI Improves Survival and Should Be Standard Practice!

New Insights Into Thrombus Aspiration for STEMI: Results From the TOTAL Angiographic Core Lab

Aspiration Thrombectomy in STEMI: Data Synthesis, and How to Identify Patients Who Might Benefit

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

Pragmatic Simple Trials and Big Data: Advantages and Caveats

Debate: Making the Case for Very Limited Use of Cangrelor!

Debate: Making the Case for Cangrelor Use in All PCI Patients!

Transitioning Between Cangrelor and Oral P2Y12 Inhibitors: All the Permutations

Cangrelor Deep Dive: What Have We Learned From the CHAMPION Trials?

“Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX

Cangrelor IV: Transitioning to Oral ADP Antagonists

Cangrelor III: Effects on Intraprocedural and Postprocedural Stent Thrombosis

Cangrelor II: Perspectives on in Whom to Actually Use It

Cangrelor I: Data Essentials From the Champion Trials

The RE-DUAL PCI Trial (Dabigatran in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content